Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2008-07-01
2008-07-01
Keys, Rosalynd (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S256000, C514S317000, C514S327000, C514S331000, C514S534000, C514S601000, C514S604000, C546S293000, C546S298000, C560S009000, C560S018000, C560S027000, C560S048000, C564S080000, C564S086000, C564S088000, C564S092000
Reexamination Certificate
active
07393873
ABSTRACT:
N-aryl arylsulfonamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
REFERENCES:
patent: 5250549 (1993-10-01), Yoshino et al.
patent: 6403607 (2002-06-01), Hidaka et al.
patent: 7238717 (2007-07-01), Fleming et al.
patent: 2002/0061599 (2002-05-01), Elling et al.
patent: 03544409 (1986-10-01), None
patent: 2290431 (1976-06-01), None
patent: WO 95/33461 (1995-12-01), None
patent: WO 03/099773 (2003-12-01), None
Derwent abstract of FR 2290431A, Jul. 1976.
CAS Abstract 1988: 131304 (1988).
CAS Registry No. 392305-40-7 (Feb. 2002).
Xiaohui Du, et al.,Chemistry&Biology, 7 (9), pp. 733-742, (2000).
S. Rajagopalan, et al.,Proc. Indian Acad. Sci. Sect. A., 15 (15), pp. 432-436, (1941).
Milton C. Kloetzel, et al.,Journal of Medicinal and Pharmaceutical Chemistry, 1(3), pp. 197-211, (1959).
Anthony Neville J.
Lim John Jin
Su Dai-Shi
Wood Michael R.
Camara Valerie J.
Keys Rosalynd
Merck & Co. , Inc.
Yang Mollie M.
LandOfFree
Arylsulfonamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806996